Global IVF Services Market (2021 to 2030) - Players Include Bangkok IVF Center, Fertility Associates and Morpheus IVF Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "IVF Services Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global IVF services market.

The global IVF services market is expected to grow from $12.92 billion in 2020 to $14.34 billion in 2021 at a compound annual growth rate (CAGR) of 11%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $22.859 billion in 2025 at a CAGR of 12%.

Companies Mentioned

• Ambroise Par Group
• amedes MVZ Koln GmbH
• AMP Center St Roch
• AVA Clinic Scanfert
• Bangkok IVF center
• Betamedics
• Bloom Fertility and Healthcare
• Bourn Hall Fertility Center
• Biofertility Center
• Chelsea and Westminster Hospital (Assisted Conception Unit)
• Cloudnine Fertility
• CHA Fertility Center
• Fertility Associates
• Genea Oxford Fertility
• Klinika Bocian
• Morpheus IVF
• Manipal Fertility
• Southern California Reproductive Center
• Monash IVF
• ManorIVF
• Fertility First
• Shanghai Ji Ai Genetics & IVF Institute
• Cologne GmbH
• Center for Advanced Reproductive Medicine and Infertility
• Cardone Reproductive Medicine and Infertility

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

The IVF services market consists of sales of in-vitro fertilization (IVF) services by entities (organizations, sole traders and partnerships) that provide these services. IVF is one of the more widely known types of assisted reproductive technology used to address infertility. IVF is a process of fertilization where an egg is combined with sperm outside the body, in vitro ("in glass"). Only goods and services traded between entities or sold to end consumers are included.

Platelet-rich plasma (PRP) is the latest technique increasingly used for improving IVF success rate in patients with recurrent implantation failures. PRP is used alongside fertility treatments like IVF to improve the egg quality, uterine lining thickness and endometrial receptivity, and the treatment is primarily for the recurrent implantation failure over multiple IVF cycles. According to an article published by the Journal of Assisted Reproduction and Genetics, women treated with PRP experienced a significant improvement in Follicle-Stimulating Hormone (FSH), Anti-Mullerian Hormone (AMH) and Antral Follicle Count (AFC) and help improve fertility.

The IVF services market covered in this report is segmented by cycle type into fresh IVF cycles (non-donor); thawed IVF cycles(non-donor); donor egg IVF cycles and by service provider into fertility clinics; hospitals; surgical centers; clinical research institutes.

The rising infertility rate contributed to the growth of the in-vitro fertilization (IVF) services market. Infertility is known as the inability to conceive within 12 months. The global fertility rates fell from 3.2 live births per woman in 1990 to 2.5 live births per woman in 2019. According to the US Department of Health and Human Services, around 12 to 13 couples in 100 have a problem in conceiving. Moreover, according to the Indian Journal of Community Medicine, 15 to 20 million infertility cases are in India alone. The rising infertility rate made people resort to IVF services contributing to the growth of the market.

The high cost of IVF services limits the in-vitro fertilization (IVF) services market. For instance, the cost of a basic IVF package ranges from $4,700 to $20,000, and the average price in the USA is around $12,000. The total cost of a single IVF cycle can range between $8,000 to $30,000. According to FertilityIQ, in 2018, the cost of IVF services was around $22,000, which is now increasing. In emerging economies like India, the cost of IVF services ranges from INR 70,000 to INR 300,000. The high cost of IVF services makes it unavailable to low- and middle-income populations, negatively affecting the IVF services' market growth.

For more information about this report visit https://www.researchandmarkets.com/r/ati6pz